Loading…
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
In the original publication, Figure 3 showed an upward directed arrow for improvement in the monthly migraine headache days. However, the direction of the arrow has been corrected to downward direction, to present the improvement in monthly migraine headache days.
Saved in:
Published in: | Quality of life research 2021-02, Vol.30 (2), p.465-466 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In the original publication, Figure 3 showed an upward directed arrow for improvement in the monthly migraine headache days. However, the direction of the arrow has been corrected to downward direction, to present the improvement in monthly migraine headache days. |
---|---|
ISSN: | 0962-9343 1573-2649 |
DOI: | 10.1007/s11136-020-02720-1 |